SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-001924
Filing Date
2021-01-27
Accepted
2021-01-27 17:28:48
Documents
12
Period of Report
2021-01-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39588
  Complete submission text file 0001493152-21-001924.txt   212920

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mtnb-20210126.xsd EX-101.SCH 2781
3 XBRL LABEL FILE mtnb-20210126_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE mtnb-20210126_pre.xml EX-101.PRE 22727
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3643
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 21561079
SIC: 2834 Pharmaceutical Preparations